T.Man Pharmaceutical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,231	2,213	1,972	2,017	1,260	895.52
Other Revenue	19.03	13.35	7.81	8.05	3.43	5.26
Revenue	2,250	2,226	1,980	2,025	1,263	900.78
Revenue Growth (YoY)	5.63%	12.42%	-2.20%	60.26%	40.25%	-
Cost of Revenue	1,126	1,133	1,003	923.57	861.26	572.32
Gross Profit	1,124	1,093	976.84	1,101	402.08	328.46
Selling, General & Admin	576.99	546.65	496.43	452.32	313.35	248.35
Operating Expenses	577.87	543.35	451.8	492.88	321.07	254.23
Operating Income	546.56	549.98	525.04	608.21	81.01	74.23
Interest Expense	-27.8	-18.63	-14.85	-16.98	-7.18	-9.09
Pretax Income	518.76	531.36	510.19	591.23	73.83	65.15
Income Tax Expense	77.77	80.65	79.1	118.71	17.44	5.25
Earnings From Continuing Operations	440.99	450.7	431.09	472.52	56.39	59.89
Minority Interest in Earnings	-0	-0	-0	-	-	-
Net Income	440.99	450.7	431.09	472.52	56.39	59.89
Net Income to Common	440.99	450.7	431.09	472.52	56.39	59.89
Net Income Growth	5.22%	4.55%	-8.77%	737.91%	-5.84%	-
Shares Outstanding (Basic)	379	343	275	250	72	67
Shares Outstanding (Diluted)	379	343	275	250	72	67
Shares Change (YoY)	20.41%	24.68%	10.30%	246.21%	8.20%	-
EPS (Basic)	1.16	1.31	1.56	1.89	0.78	0.90
EPS (Diluted)	1.16	1.31	1.56	1.89	0.78	0.90
EPS Growth	-12.62%	-16.14%	-17.29%	142.02%	-12.98%	-
Free Cash Flow	350.28	345.71	62.15	289.02	196.49	128.83
Free Cash Flow Per Share	0.92	1.01	0.23	1.16	2.72	1.93
Dividend Per Share	-	0.200	0.036	-	-	-
Dividend Growth	-	455.56%	-	-	-	-
Gross Margin	49.97%	49.12%	49.33%	54.38%	31.83%	36.46%
Operating Margin	24.29%	24.71%	26.52%	30.04%	6.41%	8.24%
Profit Margin	19.60%	20.25%	21.77%	23.34%	4.46%	6.65%
Free Cash Flow Margin	15.57%	15.53%	3.14%	14.27%	15.55%	14.30%
EBITDA	654.63	645.11	611.56	678.68	148.29	143.51
EBITDA Margin	29.09%	28.98%	30.89%	33.52%	11.74%	15.93%
D&A For EBITDA	108.07	95.12	86.52	70.48	67.28	69.28
EBIT	546.56	549.98	525.04	608.21	81.01	74.23
EBIT Margin	24.29%	24.71%	26.52%	30.04%	6.41%	8.24%
Effective Tax Rate	14.99%	15.18%	15.50%	20.08%	23.62%	8.06%
Revenue as Reported	2,250	2,226	1,980	2,025	1,263	900.78
Advertising Expenses	-	113	97	89	52	34

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.